Smoking affects treatment outcome in patients with resected esophageal squamous cell carcinoma who received chemotherapy

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Zheng, Yuzhen ^a,b   Cao, Xun ^a   Wen, Jing ^a,b   Yang, Hong ^a,b   Luo, Kongjia ^a,b   Liu, Qianwen ^a,b   Huang, Qingyuan ^a,b   Chen, Junying ^a,b   Fu, Jianhua ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b Guangdong Esophageal Cancer Research Institute   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CHEMORADIOTHERAPY; CHINESE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RETROSPECTIVE STUDY; SMOKING; TREATMENT OUTCOME; TREND STUDY; ADVERSE EFFECTS; CARCINOMA, SQUAMOUS CELL; CHINA; COMPLICATION; ESOPHAGEAL NEOPLASMS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHINA; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SMOKING; TREATMENT OUTCOME;

EID: 84929484501     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123246     Document Type: Article

References (37)

1. Rice TW, Rusch VW, Apperson-Hansen C, Allen MS, Chen LQ, Hunter JG et al (2009) Worldwide esophageal cancer collaboration. Dis Esophagus 22:1-8. doi: 10.1111/j.1442-2050.2008.00901.x PMID: 19196264
2. Allum WH, Stenning SP, Bancewicz J, Clark PI, Langley RE (2009) Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol 27:5062-5067. doi: 10.1200/JCO.2009.22.2083 PMID: 19770374
3. Liu J, Hu Y, Xie X, Fu J (2012) Subcarinal node metastasis in thoracic esophageal squamous cell carcinoma. Ann Thorac Surg 93:423-427. doi: 10.1016/j.athoracsur.2011.10.011 PMID: 22178587
4. Castellsague X, Munoz N, De Stefani E, Victora CG, Castelletto R, Rolon PA et al (1999) Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. Int J Cancer 82:657-664. PMID: 10417762
5. Oze I, Matsuo K, Ito H, Wakai K, Nagata C, Mizoue T et al (2012) Cigarette smoking and esophageal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 42:63-73. doi: 10.1093/jjco/hyr170 PMID: 22131340
6. Wakai K, Inoue M, Mizoue T, Tanaka K, Tsuji I, Nagata C et al (2006) Tobacco smoking and lung cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population. Jpn J Clin Oncol 36:309-324. PMID: 16735374
7. Giovannucci E (2001) An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 10:725-731. PMID: 11440957
8. Walter V, Jansen L, Hoffmeister M, Brenner H (2014) Smoking and survival of colorectal cancer patients: systematic review and meta-analysis. Ann Oncol 25:1517-1525. doi: 10.1093/annonc/mdu040 PMID: 24692581
9. Sharp L, McDevitt J, Carsin AE, Brown C, Comber H (2014) Smoking at Diagnosis Is an Independent Prognostic Factor for Cancer-Specific Survival in Head and Neck Cancer: Findings from a Large, Population-Based Study. Cancer Epidemiol Biomarkers Prev.
10. Seibold P, Vrieling A, Heinz J, Obi N, Sinn HP, Flesch-Janys D et al (2014) Pre-diagnostic smoking behaviour and poorer prognosis in a German breast cancer patient cohort - Differential effects by tumour subtype, NAT2 status, BMI and alcohol intake. Cancer Epidemiol 38:419-426. doi: 10.1016/j.canep.2014.05.006 PMID: 24950597
11. Han MA, Kim YW, Choi IJ, Oh MG, Kim CG, Lee JY et al (2013) Association of smoking history with cancer recurrence and survival in stage III-IV male gastric cancer patients. Cancer Epidemiol Biomarkers Prev 22:1805-1812. doi: 10.1158/1055-9965.EPI-13-0385 PMID: 23904463
12. Kawaguchi T, Takada M, Kubo A, Matsumura A, Fukai S, Tamura A et al (2010) Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC. J Thorac Oncol 5:620-630. doi: 10.1097/JTO.0b013e3181d2dcd9 PMID: 20354456
13. Jiang JM, Zeng XJ, Chen JS, Li JY, Zhang KL, Wu YP et al (2006) Smoking and mortality from esophageal cancer in China: a large case-control study of 19,734 male esophageal cancer deaths and 104,846 living spouse controls. Int J Cancer 119:1427-1432. PMID: 16596648
14. Yaegashi Y, Onoda T, Morioka S, Hashimoto T, Takeshita T, Sakata K et al (2014) Joint effects of smoking and alcohol drinking on esophageal cancer mortality in Japanese men: findings from the Japan collaborative cohort study. Asian Pac J Cancer Prev 15:1023-1029. PMID: 24568445
15. Zhang F, Han H, Wang C, Wang J, Zhang G, Cao F et al (2013) A retrospective study: the prognostic value of anemia, smoking and drinking in esophageal squamous cell carcinoma with primary radiotherapy. World J Surg Oncol 11:249. doi: 10.1186/1477-7819-11-249 PMID: 24083572
16. Tsao AS, Liu D, Lee JJ, Spitz M, Hong WK (2006) Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer. Cancer 106:2428-2436. PMID: 16634096
17. Fountzilas G, Kosmidis P, Beer M, Sridhar KS, Banis K, Vritsios A et al (1992) Factors influencing complete response and survival in patients with head and neck cancer treated with platinum-based induction chemotherapy. A Hellenic Co-operative Oncology Group Study. Ann Oncol 3:553-558. PMID: 1498077
18. Aksoy S, Harputluoglu H, Guler N, Altundag K, Hayran M, Tekuzman G et al (2007) Influence of smoking history on breast cancer prognosis: retrospective study of 240 operable breast cancer patients who received adjuvant cyclophosphamide, doxorubicin, and 5-fluorouracil chemotherapy regimen. Breast J 13:431-432. PMID: 17593056
19. Johnston-Early A, Cohen MH, Minna JD, Paxton LM, Fossieck BE Jr., Ihde DC et al (1980) Smoking abstinence and small cell lung cancer survival. An association. JAMA 244:2175-2179. PMID: 6252357
20. Hamano R, Miyata H, Yamasaki M, Kurokawa Y, Hara J, Moon JH et al (2011) Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway. Clin Cancer Res 17:3029-3038. doi: 10.1158/1078-0432.CCR-10-2532 PMID: 21248297
21. Yoshioka A, Miyata H, Doki Y, Yasuda T, Yamasaki M, Motoori M et al (2008) The activation of Akt during preoperative chemotherapy for esophageal cancer correlates with poor prognosis. Oncol Rep 19:1099-1107. PMID: 18425364
22. Dasgupta P, Kinkade R, Joshi B, Decook C, Haura E, Chellappan S (2006) Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci U S A 103:6332-6337. PMID: 16601104
23. Tsurutani J, Castillo SS, Brognard J, Granville CA, Zhang C, Gills JJ et al (2005) Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells. Carcinogenesis 26:1182-1195. PMID: 15790591
24. Chen RJ, Ho YS, Guo HR, Wang YJ (2010) Long-term nicotine exposure-induced chemoresistance is mediated by activation of Stat3 and downregulation of ERK1/2 via nAChR and beta-adrenoceptors in human bladder cancer cells. Toxicol Sci 115:118-130. doi: 10.1093/toxsci/kfq028 PMID: 20106947
25. Liu Y, Liu BA (2011) Enhanced proliferation, invasion, and epithelial-mesenchymal transition of nicotine-promoted gastric cancer by periostin. World J Gastroenterol 17:2674-2680. doi: 10.3748/wjg.v17. i21.2674 PMID: 21677839
26. Edge SB BD, Compton CC, Fritz AG, Greene FL, Trotti A. (2010) American joint committee on cacer (AJCC) cancer staging manual, 7th edn. Chicago: Springer:67-72.
27. Ji X, Zhang W, Xie C, Wang B, Zhang G, Zhou F (2011) Nasopharyngeal carcinoma risk by histologic type in central China: impact of smoking, alcohol and family history. Int J Cancer 129:724-732. doi: 10.1002/ijc.25696 PMID: 20878958
28. Shitara K, Matsuo K, Hatooka S, Ura T, Takahari D, Yokota T et al (2010) Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis: a retrospective study. Cancer Sci 101:1001-1006. doi: 10.1111/j.1349-7006.2009.01466.x PMID: 20085588
29. Wang S, Takayama K, Tanaka K, Takeshita M, Nakagaki N, Ijichi K et al (2013) Nicotine induces resistance to epidermal growth factor receptor tyrosine kinase inhibitor by alpha1 nicotinic acetylcholine receptor-mediated activation in PC9 cells. J Thorac Oncol 8:719-725. doi: 10.1097/JTO.0b013e31828b51d4 PMID: 23625155
30. West KA, Castillo SS, Dennis PA (2002) Activation of the PI3K/Akt pathway and chemotherapeutic resistance. Drug Resist Updat 5:234-248. PMID: 12531180
31. Cooke JP, Bitterman H (2004) Nicotine and angiogenesis: a new paradigm for tobacco-related diseases. Ann Med 36:33-40. PMID: 15000345
32. Luo B, Soesanto Y, McClain DA (2008) Protein modification by O-linked GlcNAc reduces angiogenesis by inhibiting Akt activity in endothelial cells. Arterioscler Thromb Vasc Biol 28:651-657. doi: 10.1161/ATVBAHA.107.159533 PMID: 18174452
33. Zhang SS, Yang H, Xie X, Luo KJ, Wen J, Bella AE et al (2013) Adjuvant chemotherapy versus surgery alone for esophageal squamous cell carcinoma: a meta-analysis of randomized controlled trials and nonrandomized studies. Dis Esophagus.
34. Wang ZW, Luan ZP, Zhang W, Dong W, Fu CR, Wang YN et al (2014) Postoperative chemoradiotherapy improves survival in esophageal squamous cell cancer with extracapsular lymph node extension. Neoplasma 61:732-738. doi: 10.4149/neo-2014-089 PMID: 25150318
35. Kofoed SC, Muhic A, Baeksgaard L, Jendresen M, Gustafsen J, Holm J et al (2012) Survival after adjuvant chemoradiotherapy or surgery alone in resectable adenocarcinoma at the gastro-esophageal junction. Scand J Surg 101:26-31. PMID: 22414465
36. van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074-2084. doi: 10.1056/NEJMoa1112088 PMID: 22646630
37. Mariette C, Dahan L, Mornex F, Maillard E, Thomas PA, Meunier B et al (2014) Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901. J Clin Oncol.